QLQ-PR25 Variables | Prostate RT group | Control group | P-value |
---|---|---|---|
Mean (SD) | Mean (SD) | ||
QoL Urinary functions | |||
Baseline | 78.19 (15.11) | 77.44 (14.58) | 0.844 |
3 months | 18.75 (20.25) | 62.19 (15.67) | < 0.001* |
6 months | 15.19 (17.33) | 59.24 (18.20) | < 0.001* |
9 months | 12.5 (14.96) | 61.04 (20.56) | < 0.001* |
12 months | 11.22 (15.17) | 59.29 (22.89) | < 0.001* |
QoL Bowel functioning | |||
Baseline | 15.44 (11.26) | 8.33 (8.34) | 0.707 |
3 months | 12.5 (9.7) | 13.58 (14.83) | 0.738 |
6 months | 11.02 (8.97) | 11.96 (13.02) | 0.756 |
9 months | 8.63 (5.78) | 13.33 (13.63) | 0.108 |
12 months | 15.38 (20.93) | 14.08 (17.12) | 0.114 |
QoL Incontinence aid | |||
Baseline | 16.67 (83.34) | 31.03 (44.48) | 0.147 |
3 months | 13.54 (30.36) | 25.93 (38.49) | 0.173 |
6 months | 11.83 (29.25) | 20.29 (31.37) | 0.313 |
9 months | 10.71 (28.77) | 21.67 (34.67) | 0.239 |
12 months | 11.54 (29.73) | 28.21 (38.12) | 0.142 |
QoL ADT symptoms | |||
Baseline | 58.33 (16.08) | 68.01 (10.46) | 0.006* |
3 months | 62.33 (17.04) | 75.72 (6.19) | < 0.001* |
6 months | 64.87 (17.36) | 77.05 (4.53) | < 0.001* |
9 months | 65.87 (18.31) | 78.61 (4.52) | 0.001* |
12 months | 64.96 (18.51) | 79.06 (5.15) | 0.001* |
QoL Sexual activity | |||
Baseline | 28.92 (18.03) | 12.64 (12.32) | < 0.001* |
3 months | 16.40 (13.96) | 9.88 (11.56) | 0.058 |
6 months | 14.78 (13.56) | 8.7 (12.17) | 0.095 |
9 months | 13.1 (10.5) | 6.67 (11.34) | 0.053 |
12 months | 13.46 (10.56) | 7.69 (11) | 0.121 |
QoL Sexual functioning | |||
Baseline | 12.26 (11.83) | 2.3 (5.41) | < 0.001* |
3 months | 2.86 (5.44) | 2.47 (4.51) | 0.765 |
6 months | 2.96 (5.51) | 1.89 (3.57) | 0.431 |
9 months | 3.27 (5.71) | 0.83 (2.56) | 0.081 |
12 months | 3.53 (5.86) | 0.64 (2.31) | 0.097 |